FacebookTwitterRedditEmail

Obama’s Latest FDA Nominee: No Hidden Big Pharma Links, They Are All in Plain Sight

The FDA has been called an arm of the drug industry because of how often it smiles on questionable new drugs and new drug approvals only to issue greater warnings or even withdraw them after the drugs made billions. Remember Vioxx, Baycol, Trovan, Meridia, Seldane, Hismanal and Darvon? They are not around anymore. Why? Remember how popular statins, brand name asthma and psychiatric drugs and GERD drugs were? Once they went off patent, the FDA “discovered” serious side effects and began to list warnings. Sorry about that.

There is a stereotype of backwoods courtroom “justice” in which prosecutors and defense attorneys who appeared to be adversarial leave arm in arm and go for a beer after a judicial decision. No hard feelings. The same collegiality oozes at FDA hearings with FDA staffers seeming to suck up to industry, perhaps for jobs in which they return to squeeze their prior colleagues. (Who remembers former Texas Governor Rick Perry’s chief of staff leaning on Perry to vaccinate all the state’s girls with the Merck vaccine Gardasil after he left for industry?)

FDA advisory panels, whose recommendations the FDA usually follows, are supposed to include “patient representatives” to see that the public’s interests are balanced against Big Pharma consultants. So many doctors and researchers now live on 5 and 6 digit drug company stipends, the FDA actually relaxed conflict of interest rules a few years ago–it could not find enough unlinked doctors!

But the “patient representatives” can be a sham. At one meeting I attended, one “patient representative” was a member of the drug industry-funded National Alliance on Mental Illness (NAMI) which was investigated by Congress for its hidden Pharma income and many consider a front group. The other so-called patient representative” had given keynote speeches at NAMI. So much for transparency.

Because of the huge amount of money to be made from a blockbuster drug like Lipitor—it was the best selling drug in the world—there is a natural tension between drug companies who want to hurry the march to Wall $treet and drug regulators who want to slow it down to protect the public.

That is why the nomination of unapologetic drug industry supporter, Robert M. Califf, for FDA Commissioner is so concerning. A disclosure statement on the website of Duke Clinical Research Institute list 25 drug companies Califf receives “research” funds from including drug giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK.

Califf has gone on record that collaboration between industry and regulators is a good thing.  He told NPR, “Many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.” What?

He is known for defending Vioxx which is reported to have caused at least 50,000 heart attacks and events before its withdrawal. (Merck is said to have known about Vioxx’ cardio effects but marketed the blockbuster drug anyway.)

Califf was instrumental in the Duke drug trial of the blood thinner Xarelto and a cheerleader of the drug despite medical experts’ objections to its approval and 379 subsequent deaths. Duke, where Califf directed clinical research, is still recovering from a major research fraud scandal that resulted in terminated grants, retracted papers and a Sixty Minutes special. It is the least appropriate place from which to choose an FDA Commissioner.

If approved as FDA Commissioner, as many expect, will Califf recuse himself from decisions on the dozens of drugs whose manufacturers pay him? Or will he rule on them anyway? Either way, his nomination is a slap in the face of every honest doctor, researcher and regulator and the public that puts its trust in the FDA. In fact, if the FDA Commissioner is funded by industry, why have an FDA?

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

July 07, 2020
Richard Eskow
The War on Logic: Contradictions and Absurdities in the House’s Military Spending Bill
Daniel Beaumont
Gimme Shelter: the Brief And Strange History of CHOP (AKA CHAZ)
Richard C. Gross
Trump’s War
Patrick Cockburn
Trump’s Racism May be Blatant, But the Culture He Defends Comes Out of the Civil War and Goes Well Beyond Racial Division
Andrew Stewart
Can We Compare the George Floyd Protests to the Vietnam War Protests? Maybe, But the Analogy is Imperfect
Walden Bello
The Racist Underpinnings of the American Way of War
Nyla Ali Khan
Fallacious Arguments Employed to Justify the Revocation of Jammu and Kashmir’s Autonomy and Its Bifurcation
Don Fitz
A Statue of Hatuey
Dean Baker
Unemployment Benefits Should Depend on the Pandemic
Ramzy Baroud – Romana Rubeo
Will the ICC Investigation Bring Justice for Palestine?
Sam Pizzigati
Social Distancing for Mega-Million Fun and Profit
Dave Lindorff
Private: Why the High Dudgeon over Alleged Russian Bounties for Taliban Slaying of US Troops
George Wuerthner
Of Fire and Fish
Binoy Kampmark
Killing Koalas: the Promise of Extinction Down Under
Parth M.N.
Back to School in Rural India: Digital Divide to Digital Partition
Ed Sanders
The Burning of Newgate Prison: a Glyph
July 06, 2020
Melvin Goodman
Foreign Election Interference: Who is to Blame?
JoAnn Wypijewski
On Disposability and Rebellion: Insights From a Rank-and-File Insurgency
Marshall Auerback – Jan Frel
There’s a Hidden Economic Trendline That is Shattering the Global Trade System
Evaggelos Vallianatos
A Just and Talented Government for Our Hazardous Age
Manuel García, Jr.
Biosphere Warming in Numbers
Ron Jacobs
Kidnapping Kids: As American as the Fourth of July
Tasha Jones
Pyramids. Plantations. Projects. Penitentiaries
Binoy Kampmark
Criminalising Journalism: Australia’s National Security Craze
Eve Ottenberg
Re-Organizing Labor
Mike Garrity
How We Stopped Trump From Trashing a Critical Montana Roadless Area in Grizzly Habitat
Nino Pagliccia
The Meaning of the 1811 Independence for Today’s Venezuela
Michael Galant
We Need a Global Green New Deal
Jill Richardson
Learning Not to Look Away
Marshall Sahlins
Donald Trump at 130,000 and Rising
Weekend Edition
July 03, 2020
Friday - Sunday
Peter Linebaugh
Police and the Wealth of Nations: Déjà Vu or Unfinished Business?
Rob Urie
Class, Race and Power
John Davis
A Requiem for George Floyd
Jeffrey St. Clair
Roaming Charges: Mutiny of the Bounties!
Richard D. Wolff
Revolutionary Possibilities: Could U.S. Capitalism Turn Nationalist?
Richard Falk
When Rogue States Sanction the International Criminal Court
Louis Proyect
Smearing Black Lives Matter…From the Left
Ralph Nader
Trump and Pence – Step Aside for Professional Pandemic Scientists and Managers
Ramzy Baroud
Tearing Down the Idols of Colonialism: Why Tunisia, Africa Must Demand French Apology
Philippe Marlière
Challenging the French Republic’s Color-Blindness
Richard C. Gross
Attack, Deny
Lee Camp
Connecting the Dates – US Media Used To Stop The ‘Threat’ of Peace
Steve Martinot
The Desire to Kill
David Yearsley
The War on Kitsch
Amy Eva Alberts Warren – Rev. William Alberts
Why are Certain Christians Democratic and Others Authoritarian?
FacebookTwitterRedditEmail